MX2021010086A - Panel de biomarcadores para el diagnostico y el pronostico del cancer. - Google Patents

Panel de biomarcadores para el diagnostico y el pronostico del cancer.

Info

Publication number
MX2021010086A
MX2021010086A MX2021010086A MX2021010086A MX2021010086A MX 2021010086 A MX2021010086 A MX 2021010086A MX 2021010086 A MX2021010086 A MX 2021010086A MX 2021010086 A MX2021010086 A MX 2021010086A MX 2021010086 A MX2021010086 A MX 2021010086A
Authority
MX
Mexico
Prior art keywords
cancer
prognosis
diagnosis
biomarker panel
determining
Prior art date
Application number
MX2021010086A
Other languages
English (en)
Inventor
Sarah Schott
Christof Sohn
Aoife Gahlawat
Witte Tania Tobar
Original Assignee
Univ Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Heidelberg filed Critical Univ Heidelberg
Publication of MX2021010086A publication Critical patent/MX2021010086A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a un método para diagnosticar o pronosticar el cáncer que comprende la determinación in vitro de los niveles de metilación de la citosina dentro de los genes marcadores y/o la determinación de los niveles de expresión de los marcadores de miARN.
MX2021010086A 2019-02-21 2020-02-21 Panel de biomarcadores para el diagnostico y el pronostico del cancer. MX2021010086A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19158682 2019-02-21
EP19174483 2019-05-14
PCT/EP2020/054667 WO2020169826A1 (en) 2019-02-21 2020-02-21 Biomarker panel for diagnosis and prognosis of cancer

Publications (1)

Publication Number Publication Date
MX2021010086A true MX2021010086A (es) 2021-09-21

Family

ID=69630329

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010086A MX2021010086A (es) 2019-02-21 2020-02-21 Panel de biomarcadores para el diagnostico y el pronostico del cancer.

Country Status (10)

Country Link
US (1) US20220127678A1 (es)
EP (1) EP3927849A1 (es)
JP (1) JP2022523366A (es)
KR (1) KR20210132033A (es)
AU (1) AU2020223871A1 (es)
BR (1) BR112021016595A2 (es)
CA (1) CA3127154A1 (es)
IL (1) IL284827A (es)
MX (1) MX2021010086A (es)
WO (1) WO2020169826A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195246B (zh) * 2020-10-19 2022-08-09 中国人民解放军空军军医大学 一种肝细胞肝癌标志物及检测试剂盒
CN113061648B (zh) * 2021-03-24 2022-04-19 中山大学 一种采用Tn5转座酶辅助构建微量样品m6A修饰检测文库的方法及其应用
DE102021126650A1 (de) * 2021-10-14 2023-04-20 Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts Verfahren zur bestimmung der ansprechwahrscheinlichkeit einer malignen erkrankung auf eine behandlung mit einem pharmazeutischen hemmwirkstoff

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2940151A1 (en) * 2014-05-02 2015-11-04 Ruprecht-Karls-Universität Heidelberg Circulating miRNAs as early detection marker and prognostic marker
DK3262190T3 (da) * 2015-02-24 2021-10-11 Univ Heidelberg Ruprecht Karls Biomarkørpanel til påvisning af cancer

Also Published As

Publication number Publication date
IL284827A (en) 2021-08-31
KR20210132033A (ko) 2021-11-03
BR112021016595A2 (pt) 2021-11-03
AU2020223871A1 (en) 2021-08-26
CA3127154A1 (en) 2020-08-27
WO2020169826A1 (en) 2020-08-27
US20220127678A1 (en) 2022-04-28
JP2022523366A (ja) 2022-04-22
EP3927849A1 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
MX2021010086A (es) Panel de biomarcadores para el diagnostico y el pronostico del cancer.
Zhang et al. UCA1 regulates the growth and metastasis of pancreatic cancer by sponging miR-135a
MX2017010836A (es) Panel biomarcador para la deteccion de cancer.
Guo et al. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression
Cui et al. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer
Zhang et al. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas
WO2009115615A3 (en) Detection and prognosis of cervical cancer
EP2558598A4 (en) BIOMARKER BASED ON A MECHANISM ASSOCIATED WITH A MULTI-CARCINOMA INVASION
NZ591613A (en) Polymorphic marker rs965513 for risk assessment of thyroid cancer
MX2015011362A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
WO2009108917A3 (en) Markers for improved detection of breast cancer
MX2022012384A (es) Composiciones y metodos para cribar mutaciones en el cancer de tiroides.
WO2013153458A3 (en) Method for the prognosis and treatment of cancer metastasis
AR083357A1 (es) Metodo para el diagnostico, pronostico y tratamiento de la metastasis de cancer de mama
IN2013CN01129A (es)
Xu et al. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer
EA201370063A1 (ru) Фосфолипидом рака
CR9298A (es) Marcadores farmacogenomicos para el pronostico de tumores solidos
MXPA06014175A (es) Diagnostico o pronostico del curso del cancer de mama.
WO2008037700A3 (en) Methods for breast cancer prognosis
ATE543913T1 (de) Prognostische genexpressionssignatur für patienten mit nichtkleinzelligem lungenkrebs
IN2012DN01979A (es)
Wei et al. MiR-1, a potential predictive biomarker for recurrence in prostate cancer after radical prostatectomy
WO2015091575A3 (en) Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer
Shen et al. SHISA3 promoter methylation is a potential diagnostic and prognostic biomarker for laryngeal squamous cell carcinoma